Home › Acute Lymphoblastic Leukemia › Ohio › Columbus
Pag-aaral pangklinika para sa Acute Lymphoblastic Leukemia sa Columbus, OH
Isang pag-aaral para sa Acute Lymphoblastic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
HPC Offered for PRESERVE Expansion
Nagre-recruitObservasyonal na pag-aaral
- The Ohio State University Medical Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- at 8 pa
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
- Ohio State University, Columbus
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Nagre-recruitPhase 1/2
- The James Cancer Hospital and Solove Research Institute, Columbus
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Nationwide Children's Hospital, Columbus
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Nationwide Children's Hospital, Columbus
- The Arthur G. James Cancer Hospital/The Ohio State University Medical Center, Columbus
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
Nagre-recruitPhase 1
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Nagre-recruitPhase 1
- The Ohio State University, Columbus
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Nagre-recruitPhase 1
- Ohio State University Medical Center, Columbus
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Nagre-recruitPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Nagre-recruitPhase 1
- Nationwide Children's Hospital, Columbus
Pag-aaral para sa Acute Lymphoblastic Leukemia sa ibang lungsod
- Houston, TX28 pag-aaral
- New York City, NY22 pag-aaral
- Seattle, WA22 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Atlanta, GA20 pag-aaral
- Chicago, IL20 pag-aaral
- Memphis, TN17 pag-aaral
- Philadelphia, PA16 pag-aaral
- Washington, DC16 pag-aaral
- Los Angeles, CA15 pag-aaral
- Boston, MA15 pag-aaral
- Mountain View, CA14 pag-aaral
Iba pang pag-aaral sa Columbus
- Non-Small Cell Lung Cancer57 pag-aaral
- Kanser (lahat ng uri)40 pag-aaral
- Kanser sa Suso39 pag-aaral
- Kanser sa Ovary39 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Chronic Lymphocytic Leukemia29 pag-aaral
- Metastatic Cancer25 pag-aaral
- Multiple Myeloma25 pag-aaral
- Kanser sa Prostate25 pag-aaral
- Kanser ng Endometrium24 pag-aaral
- Colorectal Cancer24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.